Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Eczema (Atopic Dermatitis) Clinical Trials

A listing of Eczema (Atopic Dermatitis) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (7) clinical trials

The objective of this study is to investigate if the study medication is effective in reducing eczema symptoms for those with moderate to severe eczema. This is a 65-week study with up to 17 office visits.  

Phase

A research study is evaluating an investigational medication used in combination with topical therapy for adults with moderate to severe eczema (atopic dermatitis).  

Phase N/A

A research study is now underway in San Diego to evaluate an investigational medication for those who have failed to respond to prior treatments for Eczema, also known as Atopic Dermatitis. If you are interested in participating in our Eczema (Atopic Dermatitis) study, please fill out the form below or ...

Phase N/A

The primary objective of this trial is to investigate the safety, tolerability and efficacy of BI 655130 in patients with Atopic Dermatitis (AD) following repeated intravenous administrations compared to placebo.

Phase

The primary objective of this trial is to investigate the safety, tolerability and efficacy of BI 655130 in patients with Atopic Dermatitis (AD) following repeated intravenous administrations compared to placebo.

Phase

Scratch Behavior Under Standard of Care

This open label study is to evaluate the ability of a wrist-worn accelerometry device to detect scratch and sleep quantity changes in patients with Atopic Dermatitis (AD) receiving Standard of Care (SOC) treatment. Subjects, age 2 to 75 years, with symptomatic AD will be recruited. The study will be comprised ...

Phase N/A

A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis

This study will assess the efficacy and safety of MSTT1041A in participants with moderate to severe atopic dermatitis (AD). The study consists of a screening period, a 16-week treatment period, and an 8-week follow-up period.

Phase